Admixture mapping of end stage kidney disease genetic susceptibility using estimated mutual information ancestry informative markers

BMC Medical Genomics

Volumn 3, Issue , 2010, Pages

  Shlush, Liran I ^a   Bercovici, Sivan ^a   Wasser, Walter G ^b   Yudkovsky, Guennady ^a   Templeton, Alan ^c   Geiger, Dan ^a   Skorecki, Karl ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b CABRINI MEDICAL CENTER   (United States)

^c WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADMIXTURE MAPPING; ADULT; AFRICAN AMERICAN; ARTICLE; CHROMOSOME 22; CHROMOSOME 4; ETHNICITY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENETIC MARKER; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; POPULATION GENETICS; POWER ANALYSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; CHROMOSOME MAP; CHRONIC KIDNEY FAILURE; GENE LOCUS; GENETIC PREDISPOSITION; GENETICS; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; SAMPLE SIZE;

CHROMOSOME MAPPING; FEMALE; GENETIC LOCI; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SAMPLE SIZE;

EID: 77957930018     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-3-47     Document Type: Article

References (50)

1. End-stage renal disease in developing countries. V Kher, Kidney Int 2002 62 1 350 362 10.1046/j.1523-1755.2002.00426.x 12081600
2. Racial differences in the incidence of treatment for end-stage renal disease. SG Rostand KA Kirk EA Rutsky BA Pate, N Engl J Med 1982 306 21 1276 1279 10.1056/NEJM198205273062106 7040967
3. Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey. CA Jones GM McQuillan JW Kusek MS Eberhardt WH Herman J Coresh M Salive CP Jones LY Agodoa, Am J Kidney Dis 1998 32 6 992 999 10.1016/S0272-6386(98)70074-5 9856515
4. Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension. W McClellan E Tuttle A Issa, Am J Kidney Dis 1988 12 4 285 290 3263042
5. The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors. FL Brancati JC Whittle PK Whelton AJ Seidler MJ Klag, JAMA 1992 268 21 3079 3084 10.1001/jama.268.21. 3079 1433738
6. Hypertension-associated kidney disease: perhaps no more. BI Freedman JR Sedor, J Am Soc Nephrol 2008 19 11 2047 2051 10.1681/ASN.2008060621 18923054
7. End-stage renal disease in African-American and white men. 16-year MRFIT findings. MJ Klag PK Whelton BL Randall JD Neaton FL Brancati J Stamler, JAMA 1997 277 16 1293 1298 10.1001/jama.277.16.1293 9109467
8. Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors. ME Tarver-Carr NR Powe MS Eberhardt TA LaVeist RS Kington J Coresh FL Brancati, J Am Soc Nephrol 2002 13 9 2363 2370 10.1097/01.ASN. 0000026493.18542.6A 12191981
9. Common genetic variation and human traits. DB Goldstein, N Engl J Med 2009 360 17 1696 1698 10.1056/NEJMp0806284 19369660
10. End-stage renal failure in African Americans: insights in kidney disease susceptibility. BI Freedman, Nephrol Dial Transplant 2002 17 2 198 200 10.1093/ndt/17.2.198 11812863
11. Linkage heterogeneity of end-stage renal disease on human chromosome 10. BI Freedman SS Rich H Yu BH Roh DW Bowden, Kidney Int 2002 62 3 770 774 10.1046/j.1523-1755.2002.00534.x 12164858
12. Association of the tissue kallikrein gene promoter with ESRD and hypertension. H Yu Q Song BI Freedman J Chao L Chao SS Rich DW Bowden, Kidney Int 2002 61 3 1030 1039 10.1046/j.1523-1755.2002.00198.x 11849458
13. MYH9 is associated with nondiabetic end-stage renal disease in African Americans. WH Kao MJ Klag LA Meoni D Reich Y Berthier-Schaad M Li J Coresh N Patterson A Tandon NR Powe,, et al. Nat Genet 2008 40 10 1185 1192 10.1038/ng.232 18794854
14. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. JB Kopp MW Smith GW Nelson RC Johnson BI Freedman DW Bowden T Oleksyk LM McKenzie H Kajiyama TS Ahuja,, et al. Nat Genet 2008 40 10 1175 1184 10.1038/ng.226 18794856
15. Charting the ancestry of African Americans. A Salas A Carracedo M Richards V Macaulay, American journal of human genetics 2005 77 4 676 680 10.1086/491675 16175514
16. The Genetic Structure and History of Africans and African Americans. SA Tishkoff FA Reed FR Friedlaender C Ehret A Ranciaro A Froment JB Hirbo AA Awomoyi JM Bodo O Doumbo,, et al. Science 2009 19407144
17. The beauty of admixture. A Darvasi S Shifman, Nat Genet 2005 37 2 118 119 10.1038/ng0205-118 15678141
18. Mapping by admixture linkage disequilibrium: advances, limitations and guidelines. MW Smith SJ O'Brien, Nat Rev Genet 2005 6 8 623 632 10.1038/nrg1657 16012528
19. Panel construction for mapping in admixed populations via expected mutual information. S Bercovici D Geiger L Shlush K Skorecki A Templeton, Genome research 2008 18 4 661 667 10.1101/gr.073148.107 18353806
20. African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans. D Behar S Rosset S Tzur S Selig G Yudkovsky S Bercovici JB Kopp CA Winkler GW Nelson WG Wasser,, et al. Human molecular genetics 2010 1 12 19797313
21. Genetic structure, self-identified race/ethnicity, and confounding in case-control association studies. H Tang T Quertermous B Rodriguez SL Kardia X Zhu A Brown JS Pankow MA Province SC Hunt E Boerwinkle,, et al. American journal of human genetics 2005 76 2 268 275 10.1086/427888 15625622
22. A genomewide single-nucleotide-polymorphism panel with high ancestry information for African American admixture mapping. C Tian DA Hinds R Shigeta R Kittles DG Ballinger MF Seldin, American journal of human genetics 2006 79 4 640 649 10.1086/507954 16960800
23. The International HapMap Project Web site. GA Thorisson AV Smith L Krishnan LD Stein, Genome research 2005 15 11 1592 1593 10.1101/gr.4413105 16251469
24. Methods for high-density admixture mapping of disease genes. N Patterson N Hattangadi B Lane KE Lohmueller DA Hafler JR Oksenberg SL Hauser MW Smith SJ O'Brien D Altshuler,, et al. American journal of human genetics 2004 74 5 979 1000 10.1086/420871 15088269
25. Design and analysis of admixture mapping studies. CJ Hoggart MD Shriver RA Kittles DG Clayton PM McKeigue, American journal of human genetics 2004 74 5 965 978 10.1086/420855 15088268
26. Population differentiation and migration: coalescence times in a two-sex island model for autosomal and X-linked loci. S Ramachandran NA Rosenberg MW Feldman J Wakeley, Theoretical population biology 2008 74 4 291 301 10.1016/j.tpb.2008.08.003 18817799
27. A high-density admixture map for disease gene discovery in african americans. MW Smith N Patterson JA Lautenberger AL Truelove GJ McDonald A Waliszewska BD Kessing MJ Malasky C Scafe E Le,, et al. American journal of human genetics 2004 74 5 1001 1013 10.1086/420856 15088270
28. Association of Trypanolytic ApoL1 Variants with Kidney Disease in African-Americans. G Genovese DJ Friedman MD Ross L Lecordier P Uzureau BI Freedman DW Bowden CD Langefeld TK Oleksyk AU Knob,, et al. Science 20647424
29. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. S Tzur S Rosset R Shemer G Yudkovsky S Selig A Tarekegn E Bekele N Bradman WG Wasser DM Behar,, et al. Human genetics 20635188
30. Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15. GW Nelson BI Freedman DW Bowden CD Langefeld P An PJ Hicks MA Bostrom RC Johnson JB Kopp CA Winkler, Human molecular genetics
31. Non-replication and inconsistency in the genome-wide association setting. JP Ioannidis, Human heredity 2007 64 4 203 213 10.1159/000103512 17551261
32. Race and sex differences in hypertension control in CKD: results from the Kidney Early Evaluation Program (KEEP). OK Duru S Li C Jurkovitz G Bakris W Brown SC Chen A Collins M Klag PA McCullough J McGill,, et al. Am J Kidney Dis 2008 51 2 192 198 10.1053/j.ajkd.2007.09.023 18215697
33. Social environmental stressors, psychological factors, and kidney disease. MA Bruce BM Beech M Sims TN Brown SB Wyatt HA Taylor DR Williams E Crook, J Investig Med 2009 57 4 583 589 19240646
34. Survival advantage of black patients with kidney disease after acute myocardial infarction. BB Newsome WM McClellan CS Coffey JJ Allison CI Kiefe DG Warnock, Clin J Am Soc Nephrol 2006 1 5 993 999 10.2215/CJN.01251005 17699318
35. New loci associated with kidney function and chronic kidney disease. A Kottgen C Pattaro CA Boger C Fuchsberger M Olden NL Glazer A Parsa X Gao Q Yang AV Smith,, et al. Nat Genet 42 5 376 384 10.1038/ng.568 20383146
36. Genome-wide linkage analysis of serum creatinine in three isolated European populations. C Pattaro YS Aulchenko A Isaacs V Vitart C Hayward CS Franklin O Polasek I Kolcic Z Biloglav S Campbell,, et al. Kidney Int 2009 76 3 297 306 10.1038/ki.2009.135 19387472
37. Risk for rheumatic disease in relation to ethnicity and admixture. M Molokhia P McKeigue, Arthritis research 2000 2 2 115 125 10.1186/ar76 11094421
38. Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis. HM Bastian JM Roseman G McGwin Jr GS Alarcon AW Friedman BJ Fessler BA Baethge JD Reveille, Lupus 2002 11 3 152 160 10.1191/0961203302lu158oa 12004788
39. The non-muscle Myosin heavy chain 9 gene (MYH9) is not associated with lupus nephritis in African Americans. BI Freedman JC Edberg ME Comeau M Murea DW Bowden J Divers GS Alarcon EE Brown G McGwin Jr JB Kopp, et al. American journal of nephrology 32 1 66 72 10.1159/000314688 20523037
40. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. D Ge J Fellay AJ Thompson JS Simon KV Shianna TJ Urban EL Heinzen P Qiu AH Bertelsen AJ Muir,, et al. Nature 2009 461 7262 399 401 10.1038/nature08309 19684573
41. The prevalence of psoriasis in African Americans: results from a population-based study. JM Gelfand RS Stern T Nijsten SR Feldman J Thomas J Kist T Rolstad DJ Margolis, Journal of the American Academy of Dermatology 2005 52 1 23 26 10.1016/j.jaad.2004.07.045 15627076
42. Statistical software for gene mapping by admixture linkage disequilibrium. G Montana C Hoggart, Briefings in bioinformatics 2007 8 6 393 395 10.1093/bib/bbm035 17640923
43. Admixture Mapping of Quantitative Trait Loci for Blood Lipids in African-Americans. A Basu H Tang CE Lewis K North JD Curb T Quertermous TH Mosley E Boerwinkle X Zhu NJ Risch, Human molecular genetics 2009 19304782
44. A High-Density Admixture Scan in 1,670 African Americans with Hypertension. RC Deo N Patterson A Tandon GJ McDonald CA Haiman K Ardlie BE Henderson SO Henderson D Reich, PLoS Genet 2007 3 11 196 10.1371/journal.pgen. 0030196 18020707
45. Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. ML Freedman CA Haiman N Patterson GJ McDonald A Tandon A Waliszewska K Penney RG Steen K Ardlie EM John,, et al. Proc Natl Acad Sci USA 2006 103 38 14068 14073 10.1073/pnas.0605832103 16945910
46. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Y Ogura DK Bonen N Inohara DL Nicolae FF Chen R Ramos H Britton T Moran R Karaliuskas RH Duerr,, et al. Nature 2001 411 6837 603 606 10.1038/35079114 11385577
47. Reduced neutrophil count in people of African descent is due to a regulatory variant in the Duffy antigen receptor for chemokines gene. D Reich MA Nalls WH Kao EL Akylbekova A Tandon N Patterson J Mullikin WC Hsueh CY Cheng J Coresh,, et al. PLoS Genet 2009 5 1 1000360 10.1371/journal.pgen.1000360 19180233
48. A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility. D Reich N Patterson PL De Jager GJ McDonald A Waliszewska A Tandon RR Lincoln C DeLoa SA Fruhan P Cabre,, et al. Nat Genet 2005 37 10 1113 1118 10.1038/ng1646 16186815
49. Admixture mapping of white cell count: genetic locus responsible for lower white blood cell count in the Health ABC and Jackson Heart studies. MA Nalls JG Wilson NJ Patterson A Tandon JM Zmuda S Huntsman M Garcia D Hu R Li BA Beamer,, et al. American journal of human genetics 2008 82 1 81 87 10.1016/j.ajhg.2007.09.003 18179887 (Pubitemid 351726080)
50. Long-range LD can confound genome scans in admixed populations. AL Price ME Weale N Patterson SR Myers AC Need KV Shianna D Ge JI Rotter E Torres KD Taylor,, et al. American journal of human genetics 2008 83 1 132 135 author reply 135-139 10.1016/j.ajhg.2008.06.005 18606306